EORTC Quality of Life Group at ISOQOL 2026
15 Oct 2026
This year’s 33rd Annual Conference of the International Society for Quality of Life Research (ISOQOL), taking place from 18 to 21 October 2026 in Prague, Czech Republic, will feature a strong scientific presence from the EORTC Quality of Life Group (QLG). QLG investigators will present 16 abstracts, including six oral presentations and ten posters, showcasing ongoing research in patient-reported outcomes (PROs), questionnaire development and validation, paediatric oncology, survivorship, and methodological advances in health-related quality of life (HRQOL) research.
Further details on the QLG presentations can be found in the table below.
Oral Presentations
| EORTC QLG Abstracts | Practical information |
|---|---|
| The (dis-)agreement between Patient Reported Outcomes (PROs) and Proxy-/Observer-Reported Outcomes for the Assessment of Health-Related Quality of Life in Pediatric Oncology Chiara Vetrano, Austria |
Date: Monday, 19 October 2026 Time: 13:50-14:07 CEST Type: Oral Presentation Room: Virgo & Leo Presentation number: 101.1 |
| The EORTC PRO measurement system for children with cancer Chiara Vetrano, Austria |
Date: Tuesday, 20 October 2026 Time: 15:45-16:02 CEST Type: Oral Presentation Room: Virgo & Leo Presentation number: 207.1 Note: Student Oral Presentation Award Finalist |
| PROfound Impact: Standardizing EORTC Patient-Reported Outcome Data Interpretation for Oncology Practice and Research Monika Sztankay, Austria |
Date: Tuesday, 20 October 2026 Time: 13:33-13:41 CEST Type: Oral Brief Presentation Room: Meridian Presentation number: B201.2 |
| Barriers and facilitators to the completion of Patient Reported Outcome Measures (PROMs) in cancer clinical trials: A multi-perspective interview study Andreia Moura, Belgium |
Date: Tuesday, 20 October 2026 Time: 13:49-13:57 CEST Type: Oral Brief Presentation Room: Meridian Presentation number: B201.4 |
| Quality of Life Endpoints in Mesothelioma Trials: A Systematic Review Lotte van der Weijst, Belgium |
Date: Tuesday, 20 October 2026 Time: 13:41-13:49 CEST Type: Oral Brief Presentation Room: Taurus & Aquarius Presentation number: B203.3 |
| International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: the EORTC QLQ-SURV100 Lonneke van de Poll, The Netherlands |
Date: Tuesday, 20 October 2026 Time: 13:41-13:49 CEST Type: Oral Brief Presentation Room: Tycho Presentation number: B205.3 |
Poster Presentations
| EORTC QLG Abstracts | Practical information |
|---|---|
| Development of an EORTC Health-Related Quality of Life Questionnaire for Renal Cell Cancer Patients: Phases 1-2 Lisa Wintner, Austria |
Date: Tuesday, 20 October 2026 Time: 9:35-10:15 CEST Type: Poster Presentation Room: Zenit Presentation number: 2031 |
| Time-dynamic versus time-static prediction models for impaired health-related quality of life in breast cancer: A methodological comparison using international harmonized data from the EORTC BALANCE database Niclas Hubel, Austria |
Date: Tuesday, 20 October 2026 Time: 9:35-10:15 CEST Type: Poster Presentation Room: Zenit Presentation number: 2033 |
| Face and content validity of a single-item global indicator of cancer treatment burden: Evidence from cognitive interviews Andreia Moura, Belgium |
Date: Tuesday, 20 October 2026 Time: 9:35-10:15 CEST Type: Poster Presentation Room: Zenit Presentation number: 2057 |
| How much is too much? Acceptable PROM response burden in chronic conditions: A scoping review Niclas Hubel, Austria |
Date: Tuesday, 20 October 2026 Time: 14:55-15:35 CEST Type: Poster Presentation Room: Zenit Presentation number: 2030 |
| Quality of life endpoints in EORTC clinical trials: a descriptive protocol review (2010-2026) Anne Esser, Belgium |
Date: Tuesday, 20 October 2026 Time: 14:55-15:35 CEST Type: Poster Presentation Room: Zenit Presentation number: 2033 |
| Development and validation of the EORTC-PRO-AE inventory: An international mixed-methods study to establish face and content validity Alexandra Gilbert, United Kingdom |
Date: Tuesday, 20 October 2026 Time: 14:55-15:35 CEST Type: Poster Presentation Room: Zenit Presentation number: 2066 |
| Psychometric evaluation of summary scores for the EORTC CAT Core Morten Petersen, Denmark |
Date: Wednesday, 21 October 2026 Time: 9:20-10:00 CEST Type: Poster Presentation Room: Zenit Presentation number: 3021 |
| PROcoach: The European Organisation for Research and Treatment of Cancer e-learning course on the use of patient-reported outcome measures in clinical practice Monika Sztankay, Austria |
Date: Wednesday, 21 October 2026 Time: 9:20-10:00 CEST Type: Poster Presentation Room: Zenit Presentation number: 3041 |
| Stakeholder Perspectives on Assessment Modes of PROMs in Cancer Clinical Trials: A qualitative Study Claudia Seidl, Austria |
Date: Wednesday, 21 October 2026 Time: 9:20-10:00 CEST Type: Poster Presentation Room: Zenit Presentation number: 3053 |
| Single-item measures of treatment-related side effect burden in cancer: a synthesis of current guidance and evidence Tamara Jones, Australia |
Date: Wednesday, 21 October 2026 Time: 14:35-15:15 CEST Type: Poster Presentation Room: Zenit Presentation number: 3024 |
Contact
Caroline Hance (EORTC QLG Communications)
caroline.hance@eortc.org
Related News
Pink October 2026: Advancing breast cancer research, together
7 Oct 2026
Beyond survival: new CSO and EORTC recommendations call for better reporting of quality of life in adjuvant cancer trials
30 Sep 2026
EORTC presents new results in neuro-oncology at EANO
28 Sep 2026
In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group
7 Sep 2026
New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults
4 Sep 2026
New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors
25 Aug 2026
EORTC calls for a balanced and feasible European Health Data Space (EHDS)
8 Jul 2026
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
